165 related articles for article (PubMed ID: 37915478)
1. The synthetic cannabinoid 5F-MDMB-PICA enhances the metabolic activity and angiogenesis in human brain microvascular endothelial cells by upregulation of VEGF, ANG-1, and ANG-2.
Al-Eitan LN; Alahmad SZ; ElMotasem MFM; Alghamdi MA
Toxicol Res (Camb); 2023 Oct; 12(5):796-806. PubMed ID: 37915478
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice.
Glatfelter GC; Partilla JS; Baumann MH
Neuropsychopharmacology; 2022 Mar; 47(4):924-932. PubMed ID: 34802041
[TBL] [Abstract][Full Text] [Related]
3. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
[TBL] [Abstract][Full Text] [Related]
4. MDMB-FUBINACA Influences Brain Angiogenesis and the Expression of VEGF, ANG-1, and ANG-2.
Al-Eitan L; Alkhawaldeh M
Curr Vasc Pharmacol; 2023; 21(5):356-365. PubMed ID: 37711102
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
6. Linking in vitro and ex vivo CB
Janssens LK; Hudson S; Wood DM; Wolfe C; Dargan PI; Stove CP
Arch Toxicol; 2022 Nov; 96(11):2935-2945. PubMed ID: 35962200
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of the synthetic cannabinoid, 5F-MDMB-PICA, in male rats.
Krotulski AJ; Garibay N; Walther D; Walton SE; Mohr ALA; Logan BK; Baumann MH
Neuropharmacology; 2021 Nov; 199():108800. PubMed ID: 34547333
[TBL] [Abstract][Full Text] [Related]
8. The synthetic cannabinoid 5F-MDMB-PICA: A case series.
Kleis J; Germerott T; Halter S; Héroux V; Roehrich J; Schwarz CS; Hess C
Forensic Sci Int; 2020 Sep; 314():110410. PubMed ID: 32683270
[TBL] [Abstract][Full Text] [Related]
9. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.
Tokarczyk B; Jurczyk A; Krupińska J; Adamowicz P
Forensic Sci Med Pathol; 2022 Dec; 18(4):393-402. PubMed ID: 35699867
[TBL] [Abstract][Full Text] [Related]
10. Focusing on the 5F-MDMB-PICA, 4F-MDMB-BICA synthetic cannabinoids and their primary metabolites in analytical and pharmacological aspects.
Dvorácskó S; Körmöczi T; Sija É; Bende B; Weiczner R; Varga T; Ilisz I; Institóris L; Kereszty ÉM; Tömböly C; Berkecz R
Toxicol Appl Pharmacol; 2023 Jul; 470():116548. PubMed ID: 37182749
[TBL] [Abstract][Full Text] [Related]
11. Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry).
Szpot P; Nowak K; Wachełko O; Tusiewicz K; Chłopaś-Konowałek A; Zawadzki M
Forensic Toxicol; 2023 Jan; 41(1):47-58. PubMed ID: 36652054
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Profiles of 5F-MDMB-PICA in Human Urine, Serum and Hair Samples Using LC-Q Exactive HF-MS.
Qin S; Xin G; Wei J; He G; Yuan Z; Liu H; Zhang X; Wang Y; Zhang W; Lu J
J Anal Toxicol; 2022 Apr; 46(4):408-420. PubMed ID: 33860792
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F-MDMB-PICA.
Chen RJ; Zhang ZH; Yang S; Yu SC; Wang JC; Liao PY; Qiu TT; Xiao L; Xue S; Chen H; Shao WB; Hu JW; Lan Y; Chen XL; Xu Y; Zhou TM; Zhao XJ; Liu WB
Drug Test Anal; 2024 Mar; ():. PubMed ID: 38488339
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA.
Musa A; Simola N; Piras G; Caria F; Onaivi ES; De Luca MA
Brain Sci; 2020 Dec; 10(12):. PubMed ID: 33353194
[TBL] [Abstract][Full Text] [Related]
15. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
17. Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19).
Institóris L; Kovács K; Sija É; Berkecz R; Körmöczi T; Németh I; Elek I; Bakos Á; Urbán I; Pap C; Kereszty É
Clin Toxicol (Phila); 2022 Jan; 60(1):18-24. PubMed ID: 34080493
[TBL] [Abstract][Full Text] [Related]
18. The synthetic cannabinoid 5-fluoro ABICA upregulates angiogenic markers and stimulates tube formation in human brain microvascular endothelial cells.
Al-Eitan L; Abusirdaneh R
J Taibah Univ Med Sci; 2024 Apr; 19(2):359-371. PubMed ID: 38357583
[TBL] [Abstract][Full Text] [Related]
19. GC-MS/MS analysis of synthetic cannabinoids 5F-MDMB-PICA and 5F-CUMYL-PICA in forensic cases.
Ahmed H; Mujeebuddin S
Bioanalysis; 2024; 16(9):401-413. PubMed ID: 38466892
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists.
Marusich JA; Gamage TF; Zhang Y; Akinfiresoye LR; Wiley JL
Pharmacol Biochem Behav; 2022 Oct; 220():173467. PubMed ID: 36154844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
